Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-14-005574
Filing Date
2014-02-06
Accepted
2014-02-06 17:26:07
Documents
1
Period of Report
2014-02-04

Document Format Files

Seq Description Document Type Size
1 OPTIONS 2/4/2014 rrd401554.html 4  
1 OPTIONS 2/4/2014 rrd401554.xml 4 4265
  Complete submission text file 0001181431-14-005574.txt   5631
Mailing Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063
Business Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063 650-216-3500
ACELRX PHARMACEUTICALS INC (Issuer) CIK: 0001427925 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ACELRX PHARMACEUTICALS, INC. 575 CHESAPEAKE DRIVE REDWOOD CITY CA 94063
Business Address
Palmer Pamela P (Reporting) CIK: 0001511365 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35068 | Film No.: 14581113